Commitment COM-003
Post-approval commitment for PMDA-2022-0003. Category: Risk Management. Priority: medium.
Commitment ID
COM-003
Application
Authority
Pharmaceuticals and Medical Devices Agency
Category
Risk Management
Priority
medium
Status
Open
Due Date
2025-08-25
Completed At
—
Owner
Sarah Chen
Created
2023-02-01
Description
Provide confirmatory bioequivalence study for 200 mg strength
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.